Friday, June 1, 2007

BioDefense Retains Equity Solutions for Business Development

BusinessloansDefense industry news provided by Financial News USA (OTC: FNWU). U.S. BioDefense, Inc. (OTC BB:UBDE) announces Equity Solutions, Inc. has been retained to provide business development services. David Chin, CEO of U.S. BioDefense, stated, "Our company possesses a solid base to grow and is confident Equity Solutions will assist us with future development and acquisition of customers in new market segments." U.S. BioDefense is a Department of Defense Central Contractor that researches, develops, and commercializes homeland security and leading-edge biotechnologies.


Raytheon Company (NYSE: RTN) has delivered its first Joint Standoff Weapon (JSOW) Block II -- a new variant offering significantly lower unit costs and an additional payload option. "This delivery is the culmination of an effort that began three years ago to significantly reduce the cost of this weapon," said John O'Brien, Raytheon's JSOW Block II program director.


Ryanair Holdings Plc, Europe's largest low-cost airline, recently said it has placed an order for 27 Boeing (NYSE:BA) 737-800s worth $1.9 billion at list price. This brings Ryanair's total firm orders for B737-800s to 308. The airline expects to receive the first aircraft in September 2009. The Boeing Company engages in the design, development, manufacture, sale, and support of commercial jetliners, military aircraft, satellites, missile defense, and human space flight.


Northrop Grumman Corporation (NYSE:NOC) has been awarded a task order from the Centers for Medicare and Medicaid Services (CMS) to develop and implement a Web-based application that will help Medicare providers develop comprehensive assessments of patients discharged from post-acute care. Northrop Grumman is a trusted integrator of advanced health solutions, including health and benefits management systems and information security.

[Source Financial News]

No comments: